"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties";"Action Type";"Standard Text Value";"Value"
"CHEMBL149549";"";"None";"326.33";"0";"2.15";"51";"CC(=O)N1CCc2nc(O)n3cc(-c4ccccc4F)nc3c2C1";"Activity";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"0.0"
"CHEMBL356271";"";"None";"386.45";"0";"3.67";"17";"COc1ccc(-c2cn3c(O)nc4c(c3n2)CN(Cc2ccccc2)CC4)cc1";"EC50";"'='";"143.0";"nM";"6.84";"";"";"UO_0000065";"17.71";"0.32";"3.17";"10.88";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"143.0"
"CHEMBL356806";"";"None";"406.39";"0";"3.58";"36";"O=C(c1cccc(F)c1)N1CCc2nc(O)n3cc(-c4ccccc4F)nc3c2C1";"Activity";"'='";"82.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"82.0"
"CHEMBL5397931";"";"None";"385.59";"0";"3.86";"13";"CCCCCCCC/C=C\CCCCCCCC(=O)NC(CO)(CO)CO";"K";"'='";"3.6";"uM";"";"";"";"UO_0000064";"";"";"";"";"0";"CHEMBL5335759";"Binding affinity to GABAA alpha2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5331147";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"BINDING AGENT";"";"3.6"
"CHEMBL344120";"";"None";"402.43";"0";"3.75";"39";"Cc1ccccc1C(=O)N1CCc2nc(O)n3cc(-c4ccccc4F)nc3c2C1";"EC50";"'='";"134.0";"nM";"6.87";"";"";"UO_0000065";"17.08";"0.31";"3.12";"9.72";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"134.0"
"CHEMBL148740";"";"None";"356.43";"0";"3.66";"9";"Oc1nc2c(c3nc(-c4ccccc4)cn13)CN(Cc1ccccc1)CC2";"EC50";"'='";"184.0";"nM";"6.74";"";"";"UO_0000065";"18.90";"0.34";"3.08";"12.55";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"184.0"
"CHEMBL145970";"";"None";"338.39";"0";"3.01";"30";"Oc1nc2c(c3nc(-c4ccccc4F)cn13)CN(CC1CC1)CC2";"Activity";"'='";"36.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"36.0"
"CHEMBL145970";"";"None";"338.39";"0";"3.01";"30";"Oc1nc2c(c3nc(-c4ccccc4F)cn13)CN(CC1CC1)CC2";"EC50";"'='";"1162.0";"nM";"5.93";"";"";"UO_0000065";"17.54";"0.32";"2.92";"11.06";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"1162.0"
"CHEMBL342270";"";"None";"375.41";"0";"3.19";"43";"Oc1nc2c(c3nc(-c4ccccc4F)cn13)CN(Cc1ccncc1)CC2";"EC50";"'='";"99.0";"nM";"7.00";"";"";"UO_0000065";"18.66";"0.34";"3.81";"10.52";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"99.0"
"CHEMBL3681419";"BASMISANIL";"2.0";"445.47";"0";"2.63";"39; RG1662";"Cc1onc(-c2ccc(F)cc2)c1COc1ccc(C(=O)N2CCS(=O)(=O)CC2)cn1";"Efficacy";"'='";"-6.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4403775";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as reduction in DMCM induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"-6.0"
"CHEMBL4062225";"";"None";"351.37";"0";"3.25";"7; KRM-II-81";"C#Cc1ccc2c(c1)C(c1ccccn1)=NCc1c(-c3cnco3)ncn1-2";"FC";"'='";"0.66";"";"";"";"";"";"";"";"";"";"0";"CHEMBL4403724";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as increase in induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.66"
"CHEMBL146488";"";"None";"362.37";"0";"2.59";"34";"Oc1nc2c(c3nc(-c4ccccc4F)cn13)CN(c1ncccn1)CC2";"EC50";"'='";"84.0";"nM";"7.08";"";"";"UO_0000065";"19.53";"0.36";"4.49";"8.91";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"84.0"
"CHEMBL52030";"";"None";"341.37";"0";"2.35";"33; L-655708";"CCOC(=O)c1ncn2c1[C@@H]1CCCN1C(=O)c1cc(OC)ccc1-2";"Ki";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"22.76";"0.42";"5.42";"10.55";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"17.0"
"CHEMBL147842";"";"None";"406.39";"0";"3.58";"37";"O=C(c1ccc(F)cc1)N1CCc2nc(O)n3cc(-c4ccccc4F)nc3c2C1";"EC50";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"17.86";"0.33";"3.68";"10.26";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"55.0"
"CHEMBL1681893";"";"None";"424.33";"1";"6.19";"9";"Clc1ccc(-n2nc3c4c(ncc3c2OCc2cccc(Cl)c2)CCCC4)cc1";"Efficacy";"'='";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1687496";"Agonist activity at recombinant GABAA receptor subunit alpha-2 expressed in CHO cells at 3 uM by sensitive fluorometric read-out assay relative to midazolam";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"50.0"
"CHEMBL1681885";"";"None";"349.82";"1";"5.02";"14";"Clc1ccc(-n2nc3c(cnc4ccccc43)c2OCC2CC2)cc1";"Efficacy";"'='";"36.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1687496";"Agonist activity at recombinant GABAA receptor subunit alpha-2 expressed in CHO cells at 3 uM by sensitive fluorometric read-out assay relative to midazolam";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"36.0"
"CHEMBL509197";"";"None";"268.32";"0";"3.67";"87e";"CC(C)(C)OC(=O)c1cc2c(cn1)[nH]c1ccccc12";"Ki";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"29.16";"0.53";"4.15";"14.23";"0";"CHEMBL5235568";"Binding affinity to human recombinant GABAA alpha2 receptor assessed as inhibition constant incubated for 1 hrs by liquid scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233266";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"15.0"
"CHEMBL1270841";"";"None";"316.36";"0";"4.63";"97";"CC(OC(=O)c1cc2c(cn1)[nH]c1ccccc12)c1ccccc1";"Ki";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"18.97";"0.34";"1.37";"10.91";"0";"CHEMBL5235568";"Binding affinity to human recombinant GABAA alpha2 receptor assessed as inhibition constant incubated for 1 hrs by liquid scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233266";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"1000.0"
"CHEMBL358874";"";"None";"364.38";"0";"2.52";"44";"Oc1nc2c(c3nc(-c4ccccc4F)cn13)CN(Cc1c[nH]cn1)CC2";"Activity";"'='";"58.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"58.0"
"CHEMBL147590";"";"None";"424.38";"0";"3.72";"38";"O=C(c1ccc(F)c(F)c1)N1CCc2nc(O)n3cc(-c4ccccc4F)nc3c2C1";"Activity";"'='";"59.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"59.0"
"CHEMBL4759403";"";"None";"335.37";"0";"2.92";"9";"O=C1COc2cc(Nc3cc4c(cn3)ncn4CC3CC3)ccc2N1";"Efficacy";"'='";"32.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"32.0"
"CHEMBL4753738";"";"None";"385.37";"0";"3.53";"14";"CN1C(=O)C(F)(F)Oc2cc(Nc3cc4c(cn3)ncn4CC3CC3)ccc21";"Efficacy";"'='";"1.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"1.0"
"CHEMBL4776208";"";"None";"319.37";"0";"4.03";"7";"Cc1nc2cc(Nc3cc4c(cn3)ncn4CC3CC3)ccc2o1";"Efficacy";"'='";"10.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"10.0"
"CHEMBL4747220";"";"None";"345.41";"0";"3.47";"31";"Cc1cc(Nc2ccc(-n3ccnc3)nc2)nc2c1ncn2CC1CC1";"Efficacy";"'='";"4.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"4.0"
"CHEMBL4785208";"";"None";"345.41";"0";"3.47";"32";"Cc1cc(Nc2ccc(-n3ccnc3)cn2)nc2c1ncn2CC1CC1";"Efficacy";"'='";"1.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"1.0"
"CHEMBL4754539";"";"None";"363.40";"0";"3.61";"34";"Cc1c(F)c(Nc2ccc(-n3ccnc3)nc2)nc2c1ncn2CC1CC1";"Efficacy";"'='";"17.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"17.0"
"CHEMBL4760815";"";"None";"349.39";"0";"2.94";"10";"CN1C(=O)COc2ccc(Nc3cc4c(cn3)ncn4CC3CC3)cc21";"Efficacy";"'='";"10.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"10.0"
"CHEMBL1681900";"";"None";"353.85";"0";"4.74";"17";"Clc1ccc(-n2nc3c4c(ncc3c2OCC2CC2)CCCC4)cc1";"IC50";"'='";"185.0";"nM";"6.73";"";"";"UO_0000065";"19.03";"0.37";"1.99";"16.86";"0";"CHEMBL1687498";"Displacement of [3H]flumazenil from GABAA receptor subunit alpha-2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"185.0"
"CHEMBL343471";"";"None";"402.43";"0";"3.75";"40";"Cc1ccc(C(=O)N2CCc3nc(O)n4cc(-c5ccccc5F)nc4c3C2)cc1";"EC50";"'='";"327.0";"nM";"6.49";"";"";"UO_0000065";"16.12";"0.30";"2.74";"9.17";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"327.0"
"CHEMBL661";"ALPRAZOLAM";"4.0";"308.77";"0";"3.58";"Alprazolam";"Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2";"EC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"25.65";"0.49";"4.34";"18.39";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"12.0"
"CHEMBL147312";"";"None";"370.46";"0";"3.97";"18";"Cc1ccc(-c2cn3c(O)nc4c(c3n2)CN(Cc2ccccc2)CC4)cc1";"EC50";"'='";"1179.0";"nM";"5.93";"";"";"UO_0000065";"16.00";"0.29";"1.96";"11.05";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"1179.0"
"CHEMBL148044";"";"None";"374.42";"0";"3.80";"12";"Oc1nc2c(c3nc(-c4ccc(F)cc4)cn13)CN(Cc1ccccc1)CC2";"Activity";"'='";"155.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"155.0"
"CHEMBL4585261";"";"None";"321.38";"0";"3.54";"6";"CC(=O)Nc1cccc(Nc2cc3c(cn2)ncn3CC2CC2)c1";"Efficacy";"'='";"11.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"11.0"
"CHEMBL4785991";"";"None";"365.40";"0";"2.04";"23";"Cc1nc(Nc2cnc3c(c2)OCC(=O)N3C)nc2c1ncn2CC1CC1";"Efficacy";"'='";"9.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"9.0"
"CHEMBL4746471";"";"None";"433.39";"0";"3.84";"24";"CN1C(=O)COc2cc(Nc3cc4c(cc3OC(F)(F)F)ncn4CC3CC3)cnc21";"Efficacy";"'='";"16.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"16.0"
"CHEMBL146317";"";"None";"418.43";"0";"3.45";"41";"COc1ccc(C(=O)N2CCc3nc(O)n4cc(-c5ccccc5F)nc4c3C2)cc1";"EC50";"'='";"383.0";"nM";"6.42";"";"";"UO_0000065";"15.34";"0.28";"2.97";"8.03";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"383.0"
"CHEMBL1270841";"";"None";"316.36";"0";"4.63";"97";"CC(OC(=O)c1cc2c(cn1)[nH]c1ccccc12)c1ccccc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5235574";"Inhibition of human recombinant GABAA alpha2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233266";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";"";"1.0"
"CHEMBL5281056";"";"None";"258.28";"0";"3.75";"102";"c1ccc2c(c1)[nH]c1cnc3c4ccncc4[nH]c3c12";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"29.50";"0.52";"3.87";"13.28";"0";"CHEMBL5235583";"Inhibition of GABAA alpha2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233266";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"24.0"
"CHEMBL147364";"";"None";"380.45";"0";"3.86";"45";"Oc1nc2c(c3nc(-c4ccccc4F)cn13)CN(Cc1cccs1)CC2";"EC50";"'='";"67.0";"nM";"7.17";"";"";"UO_0000065";"18.86";"0.36";"3.31";"13.37";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"67.0"
"CHEMBL146230";"";"None";"380.47";"0";"4.18";"31";"Oc1nc2c(c3nc(-c4ccccc4F)cn13)CN(CC1CCCCC1)CC2";"Activity";"'='";"71.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"71.0"
"CHEMBL1681898";"";"None";"410.30";"1";"6.40";"18";"Clc1ccc(-n2nc3c4c(ncc3c2Oc2ccccc2Cl)CCCC4)cc1";"Efficacy";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL1687496";"Agonist activity at recombinant GABAA receptor subunit alpha-2 expressed in CHO cells at 3 uM by sensitive fluorometric read-out assay relative to midazolam";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";""
"CHEMBL1681898";"";"None";"410.30";"1";"6.40";"18";"Clc1ccc(-n2nc3c4c(ncc3c2Oc2ccccc2Cl)CCCC4)cc1";"IC50";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1687498";"Displacement of [3H]flumazenil from GABAA receptor subunit alpha-2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"3000.0"
"CHEMBL3647569";"";"None";"378.46";"0";"3.58";"BDBM144260";"CCn1cnc2c(-c3cccc(-c4ccc(S(C)(=O)=O)cc4)c3)cnnc21";"Ki";"'='";"56.0";"nM";"7.25";"";"280540";"UO_0000065";"19.16";"0.37";"3.67";"9.33";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"56.0"
"CHEMBL306422";"";"None";"362.35";"0";"1.95";"35; alpha-5IA";"Cc1cc(-c2nnc3c4ccccc4c(OCc4cn(C)nn4)nn23)no1";"Ki";"'='";"0.58";"nM";"9.24";"";"";"UO_0000065";"25.49";"0.47";"7.29";"8.47";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.58"
"CHEMBL4581355";"";"None";"376.44";"0";"4.43";"40; ONO-8590580";"Cc1c(F)c(Nc2ccc(-c3cn(C)cn3)cn2)cc2c1ncn2CC1CC1";"Ki";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"19.91";"0.37";"3.06";"12.38";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"32.0"
"CHEMBL4537552";"";"None";"386.43";"0";"3.61";"49; GL-II-073";"C#Cc1ccc2c(c1)C(c1ccccc1F)=N[C@H](C)c1c(C(=O)N(C)C)ncn1-2";"FC";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4403724";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as increase in induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";""
"CHEMBL3647563";"";"None";"442.49";"0";"4.64";"BDBM144254";"CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)C(C)C)cc4F)c3)cnnc21";"Ki";"'='";"61.3";"nM";"7.21";"";"280534";"UO_0000065";"16.30";"0.32";"2.57";"9.28";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"61.3"
"CHEMBL3647577";"";"None";"456.52";"1";"5.20";"BDBM144268";"CC(C)n1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)C(C)C)cc4F)c3)cnnc21";"Ki";"'='";"87.4";"nM";"7.06";"";"280560";"UO_0000065";"15.46";"0.30";"1.86";"9.08";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"87.4"
"CHEMBL3647557";"";"None";"447.52";"0";"4.53";"BDBM144248";"[C-]#[N+]c1ccc(-c2cnnc3c2ncn3CC)cc1-c1ccc(S(=O)(=O)CC)cc1OC";"Ki";"'='";"40.6";"nM";"7.39";"";"280571";"UO_0000065";"16.52";"0.32";"2.86";"8.09";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"40.6"
"CHEMBL1681887";"";"None";"403.84";"1";"5.95";"3";"Fc1ccccc1-n1nc2c(cnc3ccccc32)c1OCc1ccccc1Cl";"Efficacy";"'='";"17.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1687496";"Agonist activity at recombinant GABAA receptor subunit alpha-2 expressed in CHO cells at 3 uM by sensitive fluorometric read-out assay relative to midazolam";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"17.0"
"CHEMBL1681894";"";"None";"424.33";"1";"6.19";"10";"Clc1ccc(COc2c3cnc4c(c3nn2-c2ccc(Cl)cc2)CCCC4)cc1";"Efficacy";"'='";"42.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1687496";"Agonist activity at recombinant GABAA receptor subunit alpha-2 expressed in CHO cells at 3 uM by sensitive fluorometric read-out assay relative to midazolam";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"42.0"
"CHEMBL1681896";"";"None";"457.88";"1";"6.55";"12";"FC(F)(F)c1ccccc1COc1c2cnc3c(c2nn1-c1ccc(Cl)cc1)CCCC3";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1687498";"Displacement of [3H]flumazenil from GABAA receptor subunit alpha-2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";""
"CHEMBL1681889";"";"None";"424.33";"1";"6.19";"5";"Clc1ccc(-n2nc3c4c(ncc3c2OCc2ccccc2Cl)CCCC4)cc1";"Efficacy";"'='";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1687496";"Agonist activity at recombinant GABAA receptor subunit alpha-2 expressed in CHO cells at 3 uM by sensitive fluorometric read-out assay relative to midazolam";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"50.0"
"CHEMBL147312";"";"None";"370.46";"0";"3.97";"18";"Cc1ccc(-c2cn3c(O)nc4c(c3n2)CN(Cc2ccccc2)CC4)cc1";"Activity";"'='";"94.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"94.0"
"CHEMBL342270";"";"None";"375.41";"0";"3.19";"43";"Oc1nc2c(c3nc(-c4ccccc4F)cn13)CN(Cc1ccncc1)CC2";"Activity";"'='";"42.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"42.0"
"CHEMBL146317";"";"None";"418.43";"0";"3.45";"41";"COc1ccc(C(=O)N2CCc3nc(O)n4cc(-c5ccccc5F)nc4c3C2)cc1";"Activity";"'='";"38.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"38.0"
"CHEMBL1681895";"";"None";"407.88";"1";"5.67";"11";"Fc1ccccc1COc1c2cnc3c(c2nn1-c1ccc(Cl)cc1)CCCC3";"IC50";"'='";"154.0";"nM";"6.81";"";"";"UO_0000065";"16.70";"0.32";"1.14";"17.06";"0";"CHEMBL1687498";"Displacement of [3H]flumazenil from GABAA receptor subunit alpha-2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"154.0"
"CHEMBL146488";"";"None";"362.37";"0";"2.59";"34";"Oc1nc2c(c3nc(-c4ccccc4F)cn13)CN(c1ncccn1)CC2";"Activity";"'='";"44.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"44.0"
"CHEMBL358301";"";"None";"324.36";"0";"2.79";"27";"C=CCN1CCc2nc(O)n3cc(-c4ccccc4F)nc3c2C1";"EC50";"'='";"284.0";"nM";"6.55";"";"";"UO_0000065";"20.18";"0.37";"3.76";"12.20";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"284.0"
"CHEMBL343009";"";"None";"392.41";"0";"3.94";"19";"Oc1nc2c(c3nc(-c4ccc(F)cc4F)cn13)CN(Cc1ccccc1)CC2";"Activity";"'='";"184.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"184.0"
"CHEMBL3647535";"";"None";"397.44";"0";"2.97";"BDBM144226";"CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(N)(=O)=O)cc4)c3)cnnc21";"Ki";"'='";"5.08";"nM";"8.29";"";"280527";"UO_0000065";"20.87";"0.40";"5.32";"7.99";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"5.08"
"CHEMBL1681899";"";"None";"415.88";"1";"5.20";"19";"Clc1ccc(-n2nc3c(cnc4ccc(-n5ccnc5)cc43)c2OCC2CC2)cc1";"IC50";"'='";"2114.0";"nM";"5.67";"";"";"UO_0000065";"13.65";"0.26";"0.47";"9.82";"0";"CHEMBL1687498";"Displacement of [3H]flumazenil from GABAA receptor subunit alpha-2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"2114.0"
"CHEMBL147379";"";"None";"340.40";"0";"3.40";"29";"CCCCN1CCc2nc(O)n3cc(-c4ccccc4F)nc3c2C1";"Activity";"'='";"86.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"86.0"
"CHEMBL1681890";"";"None";"438.36";"1";"6.58";"6";"Clc1ccc(-n2nc3c4c(ncc3c2OCc2ccccc2Cl)CCCCC4)cc1";"IC50";"'='";"605.0";"nM";"6.22";"";"";"UO_0000065";"14.19";"0.28";"-0.36";"15.57";"0";"CHEMBL1687498";"Displacement of [3H]flumazenil from GABAA receptor subunit alpha-2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"605.0"
"CHEMBL1681894";"";"None";"424.33";"1";"6.19";"10";"Clc1ccc(COc2c3cnc4c(c3nn2-c2ccc(Cl)cc2)CCCC4)cc1";"IC50";"'='";"177.0";"nM";"6.75";"";"";"UO_0000065";"15.91";"0.32";"0.56";"16.91";"0";"CHEMBL1687498";"Displacement of [3H]flumazenil from GABAA receptor subunit alpha-2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"177.0"
"CHEMBL4794600";"";"None";"351.37";"0";"1.73";"22";"CN1C(=O)COc2cc(Nc3ncc4ncn(CC5CC5)c4n3)cnc21";"Efficacy";"'>'";"7.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701850";"Positive allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"7.0"
"CHEMBL343009";"";"None";"392.41";"0";"3.94";"19";"Oc1nc2c(c3nc(-c4ccc(F)cc4F)cn13)CN(Cc1ccccc1)CC2";"EC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"17.02";"0.31";"2.74";"12.44";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"210.0"
"CHEMBL4761610";"";"None";"350.38";"0";"2.34";"17";"CN1C(=O)COc2cc(Nc3cc4c(cn3)ncn4CC3CC3)cnc21";"Efficacy";"'='";"8.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"8.0"
"CHEMBL4759785";"";"None";"364.41";"0";"2.64";"18";"Cc1nc(Nc2cnc3c(c2)OCC(=O)N3C)cc2c1ncn2CC1CC1";"Efficacy";"'='";"15.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"15.0"
"CHEMBL4228824";"";"None";"372.40";"0";"3.26";"48; MP-III-022";"C#Cc1ccc2c(c1)C(c1ccccc1F)=N[C@H](C)c1c(C(=O)NC)ncn1-2";"Ki";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"17.30";"0.31";"3.18";"10.87";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"360.0"
"CHEMBL1681891";"";"None";"426.30";"1";"5.38";"7";"Clc1ccc(-n2nc3c4c(ncc3c2OCc2ccccc2Cl)CCOC4)cc1";"IC50";"'='";"461.0";"nM";"6.34";"";"";"UO_0000065";"14.86";"0.30";"0.96";"12.89";"0";"CHEMBL1687498";"Displacement of [3H]flumazenil from GABAA receptor subunit alpha-2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"461.0"
"CHEMBL1681893";"";"None";"424.33";"1";"6.19";"9";"Clc1ccc(-n2nc3c4c(ncc3c2OCc2cccc(Cl)c2)CCCC4)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1687498";"Displacement of [3H]flumazenil from GABAA receptor subunit alpha-2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";""
"CHEMBL147217";"";"None";"312.35";"0";"2.62";"26";"CCN1CCc2nc(O)n3cc(-c4ccccc4F)nc3c2C1";"Activity";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"0.0"
"CHEMBL147842";"";"None";"406.39";"0";"3.58";"37";"O=C(c1ccc(F)cc1)N1CCc2nc(O)n3cc(-c4ccccc4F)nc3c2C1";"Activity";"'='";"38.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"38.0"
"CHEMBL3647579";"";"None";"440.50";"0";"4.29";"BDBM144270";"COc1cc(S(C)(=O)=O)ccc1-c1cc(-c2cnnc3c2ncn3C(C)C)ccc1F";"Ki";"'='";"8.56";"nM";"8.07";"";"280562";"UO_0000065";"18.31";"0.36";"3.78";"9.28";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"8.56"
"CHEMBL146230";"";"None";"380.47";"0";"4.18";"31";"Oc1nc2c(c3nc(-c4ccccc4F)cn13)CN(CC1CCCCC1)CC2";"EC50";"'='";"202.0";"nM";"6.70";"";"";"UO_0000065";"17.60";"0.33";"2.51";"12.48";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"202.0"
"CHEMBL1270038";"";"None";"292.34";"0";"3.65";"96";"C#Cc1ccc2[nH]c3cnc(C(=O)OC(C)(C)C)cc3c2c1";"Ki";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"23.80";"0.43";"3.31";"12.66";"0";"CHEMBL5235568";"Binding affinity to human recombinant GABAA alpha2 receptor assessed as inhibition constant incubated for 1 hrs by liquid scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233266";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"110.0"
"CHEMBL2008708";"";"None";"258.28";"0";"3.75";"101";"c1ccc2c(c1)[nH]c1cnc3c4cccnc4[nH]c3c12";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"30.67";"0.54";"4.17";"13.81";"0";"CHEMBL5235583";"Inhibition of GABAA alpha2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233266";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"12.0"
"CHEMBL3647558";"";"None";"438.51";"0";"3.69";"BDBM144249";"CCn1cnc2c(-c3ccc(O)c(-c4ccc(S(=O)(=O)CC)cc4OC)c3)cnnc21";"Ki";"'='";"92.2";"nM";"7.04";"";"280572";"UO_0000065";"16.04";"0.31";"3.35";"6.56";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"92.2"
"CHEMBL4441634";"";"None";"388.86";"0";"4.84";"21; NS16085";"CC(C)(O)c1ccc2c(c1)ncn2-c1cccc(-c2cc(C#N)ccc2Cl)n1";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";""
"CHEMBL4553352";"";"None";"398.44";"0";"3.80";"50; GL-II-075";"C#Cc1ccc2c(c1)C(c1ccccc1F)=N[C@H](C)c1c(C(=O)NC3CC3)ncn1-2";"FC";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4403724";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as increase in induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";""
"CHEMBL4228824";"";"None";"372.40";"0";"3.26";"48; MP-III-022";"C#Cc1ccc2c(c1)C(c1ccccc1F)=N[C@H](C)c1c(C(=O)NC)ncn1-2";"FC";"'='";"0.5";"";"";"";"";"";"";"";"";"";"0";"CHEMBL4403724";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as increase in induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.5"
"CHEMBL3647553";"";"None";"480.57";"1";"5.22";"BDBM144244";"CCS(=O)(=O)c1ccc(-c2cc(-c3cnnc4c3ncn4C3CCCC3)ccc2F)c(OC)c1";"Ki";"'='";"118.0";"nM";"6.93";"";"280567";"UO_0000065";"14.42";"0.28";"1.71";"7.97";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"118.0"
"CHEMBL1783256";"AZD6280";"1.0";"366.42";"0";"3.04";"20; AZD6280, Table 2, R3C3";"CCCNC(=O)c1nnc2c(-c3cc(OC)ccc3OC)cccc2c1N";"Ki";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"22.65";"0.42";"5.26";"8.35";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"5.0"
"CHEMBL147364";"";"None";"380.45";"0";"3.86";"45";"Oc1nc2c(c3nc(-c4ccccc4F)cn13)CN(Cc1cccs1)CC2";"Activity";"'='";"54.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"54.0"
"CHEMBL146302";"";"None";"406.39";"0";"3.58";"35";"O=C(c1ccccc1F)N1CCc2nc(O)n3cc(-c4ccccc4F)nc3c2C1";"EC50";"'='";"256.0";"nM";"6.59";"";"";"UO_0000065";"16.22";"0.30";"3.01";"9.32";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"256.0"
"CHEMBL147590";"";"None";"424.38";"0";"3.72";"38";"O=C(c1ccc(F)c(F)c1)N1CCc2nc(O)n3cc(-c4ccccc4F)nc3c2C1";"EC50";"'='";"238.0";"nM";"6.62";"";"";"UO_0000065";"15.61";"0.29";"2.90";"9.36";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"238.0"
"CHEMBL3647578";"";"None";"468.55";"1";"5.07";"BDBM144269";"COc1cc(S(=O)(=O)C(C)C)ccc1-c1cc(-c2cnnc3c2ncn3C(C)C)ccc1F";"Ki";"'='";"19.1";"nM";"7.72";"";"280561";"UO_0000065";"16.47";"0.32";"2.65";"8.88";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"19.1"
"CHEMBL1783247";"";"None";"334.42";"0";"3.64";"Table 2, R2C1";"CCCNC(=O)c1nnc2c(-c3cc(C)ccc3C)cccc2c1N";"Ki";"'='";"5.495";"nM";"8.26";"";"";"UO_0000065";"24.70";"0.45";"4.62";"10.21";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"8.26"
"CHEMBL496990";"";"None";"291.74";"1";"5.00";"99b";"Clc1ccc2c(c1)[nH]c1c2ncc2[nH]c3ccccc3c21";"Ki";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"27.15";"0.52";"2.92";"17.81";"0";"CHEMBL5235568";"Binding affinity to human recombinant GABAA alpha2 receptor assessed as inhibition constant incubated for 1 hrs by liquid scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233266";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"12.0"
"CHEMBL2008708";"";"None";"258.28";"0";"3.75";"101";"c1ccc2c(c1)[nH]c1cnc3c4cccnc4[nH]c3c12";"Ki";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"30.67";"0.54";"4.17";"13.81";"0";"CHEMBL5235568";"Binding affinity to human recombinant GABAA alpha2 receptor assessed as inhibition constant incubated for 1 hrs by liquid scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233266";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"12.0"
"CHEMBL499814";"";"None";"226.28";"0";"3.50";"87j";"CCCOc1cc2c(cn1)[nH]c1ccccc12";"Ki";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"32.19";"0.59";"3.78";"19.21";"0";"CHEMBL5235568";"Binding affinity to human recombinant GABAA alpha2 receptor assessed as inhibition constant incubated for 1 hrs by liquid scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233266";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"52.0"
"CHEMBL497197";"";"None";"287.32";"0";"4.36";"99c";"COc1ccc2c(c1)[nH]c1c2ncc2[nH]c3ccccc3c21";"Ki";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"27.57";"0.49";"3.56";"14.75";"0";"CHEMBL5235568";"Binding affinity to human recombinant GABAA alpha2 receptor assessed as inhibition constant incubated for 1 hrs by liquid scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233266";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"12.0"
"CHEMBL3647538";"";"None";"466.54";"0";"4.65";"BDBM144229";"CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)C5CCC5)cc4OC)c3)cnnc21";"Ki";"'='";"9.51";"nM";"8.02";"";"280530";"UO_0000065";"17.19";"0.33";"3.37";"9.22";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"9.51"
"CHEMBL3647540";"";"None";"461.52";"0";"4.69";"BDBM144231";"CC(C)S(=O)(=O)c1ccc(-c2cc(-c3cnnc4c3ncn4C3CC3)ccc2F)c(C#N)c1";"Ki";"'='";"296.0";"nM";"6.53";"";"280542";"UO_0000065";"14.15";"0.27";"1.84";"6.43";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"296.0"
"CHEMBL3647571";"";"None";"423.47";"0";"3.54";"BDBM144262";"CNS(=O)(=O)c1ccc(-c2cc(-c3cnnc4c3ncn4C3CC3)ccc2F)cc1";"Ki";"'='";"19.0";"nM";"7.72";"";"280544";"UO_0000065";"18.23";"0.35";"4.18";"8.60";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"19.0"
"CHEMBL3647580";"";"None";"458.95";"1";"5.33";"BDBM144271";"CCS(=O)(=O)c1ccc(-c2cc(-c3cnnc4c3ncn4C(C)C)ccc2F)c(Cl)c1";"Ki";"'='";"14.4";"nM";"7.84";"";"280563";"UO_0000065";"17.09";"0.35";"2.51";"10.09";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"14.4"
"CHEMBL3647552";"";"None";"467.53";"0";"4.07";"BDBM144243";"COc1cc(S(N)(=O)=O)ccc1-c1cc(-c2cnnc3c2ncn3C2CCCC2)ccc1F";"Ki";"'='";"91.4";"nM";"7.04";"";"280566";"UO_0000065";"15.06";"0.29";"2.97";"6.23";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"91.4"
"CHEMBL661";"ALPRAZOLAM";"4.0";"308.77";"0";"3.58";"Alprazolam";"Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2";"Activity";"'='";"333.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"333.0"
"CHEMBL1681896";"";"None";"457.88";"1";"6.55";"12";"FC(F)(F)c1ccccc1COc1c2cnc3c(c2nn1-c1ccc(Cl)cc1)CCCC3";"Efficacy";"'='";"94.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1687496";"Agonist activity at recombinant GABAA receptor subunit alpha-2 expressed in CHO cells at 3 uM by sensitive fluorometric read-out assay relative to midazolam";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"94.0"
"CHEMBL1681887";"";"None";"403.84";"1";"5.95";"3";"Fc1ccccc1-n1nc2c(cnc3ccccc32)c1OCc1ccccc1Cl";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"21.54";"0.41";"2.75";"21.78";"0";"CHEMBL1687498";"Displacement of [3H]flumazenil from GABAA receptor subunit alpha-2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"2.0"
"CHEMBL1681885";"";"None";"349.82";"1";"5.02";"14";"Clc1ccc(-n2nc3c(cnc4ccccc43)c2OCC2CC2)cc1";"IC50";"'='";"472.0";"nM";"6.33";"";"";"UO_0000065";"18.08";"0.35";"1.31";"15.84";"0";"CHEMBL1687498";"Displacement of [3H]flumazenil from GABAA receptor subunit alpha-2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"472.0"
"CHEMBL1681897";"";"None";"407.88";"1";"5.67";"13";"Fc1ccc(COc2c3cnc4c(c3nn2-c2ccc(Cl)cc2)CCCC4)cc1";"IC50";"'='";"57.0";"nM";"7.24";"";"";"UO_0000065";"17.76";"0.34";"1.57";"18.14";"0";"CHEMBL1687498";"Displacement of [3H]flumazenil from GABAA receptor subunit alpha-2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"57.0"
"CHEMBL4792380";"";"None";"294.36";"0";"3.59";"2";"COc1ccc(Nc2cc3c(cn2)ncn3CC2CC2)cc1";"Efficacy";"'='";"20.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"20.0"
"CHEMBL1681888";"";"None";"429.86";"1";"5.53";"4";"Clc1ccccc1COc1c2cnc3ccccc3c2nn1-c1ccc2c(c1)OCO2";"Efficacy";"'='";"19.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1687496";"Agonist activity at recombinant GABAA receptor subunit alpha-2 expressed in CHO cells at 3 uM by sensitive fluorometric read-out assay relative to midazolam";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"19.0"
"CHEMBL3647549";"";"None";"425.49";"0";"3.79";"BDBM144240";"CNS(=O)(=O)c1ccc(-c2cc(-c3cnnc4c3ncn4C(C)C)ccc2F)cc1";"Ki";"'='";"16.4";"nM";"7.79";"";"280557";"UO_0000065";"18.30";"0.35";"4.00";"8.67";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"16.4"
"CHEMBL3647533";"";"None";"424.50";"0";"4.50";"BDBM144224";"CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)C(C)C)cc4)c3)cnnc21";"Ki";"'='";"31.1";"nM";"7.51";"";"280525";"UO_0000065";"17.68";"0.34";"3.01";"9.66";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"31.1"
"CHEMBL3647554";"";"None";"440.50";"0";"3.61";"BDBM144245";"CCn1cnc2c(-c3ccc(CO)c(-c4ccc(S(=O)(=O)CC)cc4F)c3)cnnc21";"Ki";"'='";"678.0";"nM";"6.17";"";"280568";"UO_0000065";"14.00";"0.27";"2.56";"6.30";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"678.0"
"CHEMBL145983";"";"None";"374.42";"0";"3.80";"11";"Oc1nc2c(c3nc(-c4cccc(F)c4)cn13)CN(Cc1ccccc1)CC2";"EC50";"'='";"154.0";"nM";"6.81";"";"";"UO_0000065";"18.19";"0.33";"3.01";"12.70";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"154.0"
"CHEMBL358519";"";"None";"340.36";"0";"2.54";"52";"CCC(=O)N1CCc2nc(O)n3cc(-c4ccccc4F)nc3c2C1";"EC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"20.44";"0.38";"4.42";"9.84";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"110.0"
"CHEMBL3647573";"";"None";"440.48";"0";"4.57";"BDBM144264";"CCS(=O)(=O)c1ccc(-c2cc(-c3cnnc4c3ncn4C3CC3)ccc2F)c(F)c1";"Ki";"'='";"67.8";"nM";"7.17";"";"280546";"UO_0000065";"16.27";"0.32";"2.60";"9.22";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"67.8"
"CHEMBL1080588";"";"None";"352.14";"0";"3.19";"38; RO4938581";"FC(F)c1ncn2c1Cn1ncnc1-c1cc(Br)ccc1-2";"Ki";"'='";"185.0";"nM";"6.73";"";"";"UO_0000065";"19.12";"0.44";"3.54";"13.87";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"185.0"
"CHEMBL4553352";"";"None";"398.44";"0";"3.80";"50; GL-II-075";"C#Cc1ccc2c(c1)C(c1ccccc1F)=N[C@H](C)c1c(C(=O)NC3CC3)ncn1-2";"Ki";"'='";"789.0";"nM";"6.10";"";"";"UO_0000065";"15.32";"0.28";"2.30";"10.30";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"789.0"
"CHEMBL3647564";"";"None";"435.48";"0";"3.98";"BDBM144255";"CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4C#N)c3)cnnc21";"Ki";"'='";"39.2";"nM";"7.41";"";"280535";"UO_0000065";"17.01";"0.33";"3.43";"7.30";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"39.2"
"CHEMBL3647570";"";"None";"390.47";"0";"3.51";"BDBM144261";"CCn1cnc2c(-c3cccc(-c4ccc5c(c4)CCS5(=O)=O)c3)cnnc21";"Ki";"'='";"102.0";"nM";"6.99";"";"280541";"UO_0000065";"17.91";"0.34";"3.48";"8.99";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"102.0"
"CHEMBL3647541";"";"None";"422.49";"0";"4.43";"BDBM144232";"CCS(=O)(=O)c1ccc(-c2cc(-c3cnnc4c3ncn4C3CC3)ccc2F)cc1";"Ki";"'='";"31.1";"nM";"7.51";"";"280543";"UO_0000065";"17.77";"0.34";"3.08";"9.66";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"31.1"
"CHEMBL1681891";"";"None";"426.30";"1";"5.38";"7";"Clc1ccc(-n2nc3c4c(ncc3c2OCc2ccccc2Cl)CCOC4)cc1";"Efficacy";"'='";"32.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1687496";"Agonist activity at recombinant GABAA receptor subunit alpha-2 expressed in CHO cells at 3 uM by sensitive fluorometric read-out assay relative to midazolam";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"32.0"
"CHEMBL1681886";"";"None";"420.30";"1";"6.46";"2";"Clc1ccc(-n2nc3c(cnc4ccccc43)c2OCc2ccccc2Cl)cc1";"IC50";"'='";"265.0";"nM";"6.58";"";"";"UO_0000065";"15.65";"0.31";"0.12";"16.47";"0";"CHEMBL1687498";"Displacement of [3H]flumazenil from GABAA receptor subunit alpha-2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"265.0"
"CHEMBL1681888";"";"None";"429.86";"1";"5.53";"4";"Clc1ccccc1COc1c2cnc3ccccc3c2nn1-c1ccc2c(c1)OCO2";"IC50";"'='";"155.0";"nM";"6.81";"";"";"UO_0000065";"15.84";"0.30";"1.28";"11.66";"0";"CHEMBL1687498";"Displacement of [3H]flumazenil from GABAA receptor subunit alpha-2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"155.0"
"CHEMBL1681889";"";"None";"424.33";"1";"6.19";"5";"Clc1ccc(-n2nc3c4c(ncc3c2OCc2ccccc2Cl)CCCC4)cc1";"IC50";"'='";"271.0";"nM";"6.57";"";"";"UO_0000065";"15.48";"0.31";"0.38";"16.44";"0";"CHEMBL1687498";"Displacement of [3H]flumazenil from GABAA receptor subunit alpha-2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"271.0"
"CHEMBL1681899";"";"None";"415.88";"1";"5.20";"19";"Clc1ccc(-n2nc3c(cnc4ccc(-n5ccnc5)cc43)c2OCC2CC2)cc1";"Efficacy";"'='";"35.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1687496";"Agonist activity at recombinant GABAA receptor subunit alpha-2 expressed in CHO cells at 3 uM by sensitive fluorometric read-out assay relative to midazolam";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"35.0"
"CHEMBL1681895";"";"None";"407.88";"1";"5.67";"11";"Fc1ccccc1COc1c2cnc3c(c2nn1-c1ccc(Cl)cc1)CCCC3";"Efficacy";"'='";"83.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1687496";"Agonist activity at recombinant GABAA receptor subunit alpha-2 expressed in CHO cells at 3 uM by sensitive fluorometric read-out assay relative to midazolam";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"83.0"
"CHEMBL1681892";"";"None";"452.39";"1";"6.82";"8";"CC1(C)CCc2ncc3c(OCc4ccccc4Cl)n(-c4ccc(Cl)cc4)nc3c2C1";"Efficacy";"'='";"23.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1687496";"Agonist activity at recombinant GABAA receptor subunit alpha-2 expressed in CHO cells at 3 uM by sensitive fluorometric read-out assay relative to midazolam";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"23.0"
"CHEMBL1681892";"";"None";"452.39";"1";"6.82";"8";"CC1(C)CCc2ncc3c(OCc4ccccc4Cl)n(-c4ccc(Cl)cc4)nc3c2C1";"IC50";"'='";"213.0";"nM";"6.67";"";"";"UO_0000065";"14.75";"0.29";"-0.15";"16.70";"0";"CHEMBL1687498";"Displacement of [3H]flumazenil from GABAA receptor subunit alpha-2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"213.0"
"CHEMBL148044";"";"None";"374.42";"0";"3.80";"12";"Oc1nc2c(c3nc(-c4ccc(F)cc4)cn13)CN(Cc1ccccc1)CC2";"EC50";"'='";"245.0";"nM";"6.61";"";"";"UO_0000065";"17.66";"0.32";"2.81";"12.32";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"245.0"
"CHEMBL356161";"";"None";"374.42";"0";"3.80";"10";"Oc1nc2c(c3nc(-c4ccccc4F)cn13)CN(Cc1ccccc1)CC2";"EC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"20.56";"0.38";"3.90";"14.35";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"20.0"
"CHEMBL1783281";"";"None";"350.42";"0";"3.34";"Table 2, R3C1";"CCCNC(=O)c1nnc2c(-c3cc(C)ccc3OC)cccc2c1N";"Ki";"'='";"6.166";"nM";"8.21";"";"";"UO_0000065";"23.43";"0.43";"4.87";"9.11";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"8.21"
"CHEMBL1783281";"";"None";"350.42";"0";"3.34";"Table 2, R3C1";"CCCNC(=O)c1nnc2c(-c3cc(C)ccc3OC)cccc2c1N";"FC";"'='";"0.52";"";"";"";"";"";"";"";"";"";"0";"CHEMBL4403724";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as increase in induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.52"
"CHEMBL1783280";"";"None";"337.38";"0";"2.42";"Table 2, R5C1";"CCCNC(=O)c1nnc2c(-c3cnccc3OC)cccc2c1N";"FC";"'='";"0.29";"";"";"";"";"";"";"";"";"";"0";"CHEMBL4403724";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as increase in induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.29"
"CHEMBL1783258";"";"None";"352.39";"0";"2.65";"Table 2, R2C3";"CCNC(=O)c1nnc2c(-c3cc(OC)ccc3OC)cccc2c1N";"FC";"'='";"0.23";"";"";"";"";"";"";"";"";"";"0";"CHEMBL4403724";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as increase in induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.23"
"CHEMBL1080588";"";"None";"352.14";"0";"3.19";"38; RO4938581";"FC(F)c1ncn2c1Cn1ncnc1-c1cc(Br)ccc1-2";"Efficacy";"'='";"-4.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4403775";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as reduction in DMCM induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"-4.0"
"CHEMBL4581355";"";"None";"376.44";"0";"4.43";"40; ONO-8590580";"Cc1c(F)c(Nc2ccc(-c3cn(C)cn3)cn2)cc2c1ncn2CC1CC1";"Efficacy";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4403775";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as reduction in DMCM induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.0"
"CHEMBL4760677";"";"None";"342.41";"0";"4.28";"27";"Cc1cc(Nc2ccc(-c3ccncc3)cn2)nc2c1ncn2C1CC1";"Efficacy";"'='";"11.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"11.0"
"CHEMBL4757188";"";"None";"419.80";"0";"4.76";"28";"FC(F)(F)c1cc(Nc2ccc(-n3cnc(Cl)c3)nc2)nc2c1ncn2C1CC1";"Efficacy";"'='";"19.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"19.0"
"CHEMBL4758608";"";"None";"396.46";"0";"4.00";"30";"Cc1cc(Nc2ccc(-c3cnc4ncccn34)cn2)nc2c1ncn2CC1CC1";"Efficacy";"'='";"10.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"10.0"
"CHEMBL4749423";"";"None";"384.37";"0";"4.19";"33";"Fc1cc(Nc2nc3c(ncn3CC3CC3)c(F)c2F)ccc1-n1ccnc1";"Efficacy";"'='";"10.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"10.0"
"CHEMBL3647548";"";"None";"411.46";"0";"3.53";"BDBM144239";"CC(C)n1cnc2c(-c3ccc(F)c(-c4ccc(S(N)(=O)=O)cc4)c3)cnnc21";"Ki";"'='";"5.82";"nM";"8.23";"";"280556";"UO_0000065";"20.01";"0.39";"4.71";"7.94";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"5.82"
"CHEMBL3647551";"";"None";"463.54";"0";"4.93";"BDBM144242";"CC(C)n1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)C(C)C)cc4C#N)c3)cnnc21";"Ki";"'='";"38.8";"nM";"7.41";"";"280559";"UO_0000065";"15.99";"0.31";"2.48";"7.30";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"38.8"
"CHEMBL4778552";"";"None";"324.38";"0";"3.60";"1";"COc1ccc(Nc2cc3c(cn2)ncn3CC2CC2)c(OC)c1";"Efficacy";"'='";"7.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"7.0"
"CHEMBL1518572";"";"None";"390.44";"0";"4.62";"ZK-93423 (89e)";"CCOC(=O)c1ncc2[nH]c3ccc(OCc4ccccc4)cc3c2c1COC";"Ki";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"21.51";"0.40";"3.78";"11.44";"0";"CHEMBL5235568";"Binding affinity to human recombinant GABAA alpha2 receptor assessed as inhibition constant incubated for 1 hrs by liquid scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233266";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"4.0"
"CHEMBL1681897";"";"None";"407.88";"1";"5.67";"13";"Fc1ccc(COc2c3cnc4c(c3nn2-c2ccc(Cl)cc2)CCCC4)cc1";"Efficacy";"'='";"41.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1687496";"Agonist activity at recombinant GABAA receptor subunit alpha-2 expressed in CHO cells at 3 uM by sensitive fluorometric read-out assay relative to midazolam";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"41.0"
"CHEMBL3647574";"";"None";"466.54";"0";"4.83";"BDBM144265";"COc1cc(S(=O)(=O)C(C)C)ccc1-c1cc(-c2cnnc3c2ncn3C2CC2)ccc1F";"Ki";"'='";"40.5";"nM";"7.39";"";"280547";"UO_0000065";"15.85";"0.31";"2.56";"8.50";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"40.5"
"CHEMBL3647545";"";"None";"452.51";"0";"4.44";"BDBM144236";"COc1cc(S(C)(=O)=O)ccc1-c1cc(-c2cnnc3c2ncn3C2CCC2)ccc1F";"Ki";"'='";"101.0";"nM";"7.00";"";"280553";"UO_0000065";"15.46";"0.30";"2.56";"8.04";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"101.0"
"CHEMBL3647547";"";"None";"424.50";"0";"4.67";"BDBM144238";"CCS(=O)(=O)c1ccc(-c2cc(-c3cnnc4c3ncn4C(C)C)ccc2F)cc1";"Ki";"'='";"23.9";"nM";"7.62";"";"280555";"UO_0000065";"17.95";"0.35";"2.95";"9.80";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"23.9"
"CHEMBL146086";"";"None";"375.41";"0";"3.19";"42";"Oc1nc2c(c3nc(-c4ccccc4F)cn13)CN(Cc1cccnc1)CC2";"Activity";"'='";"78.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"78.0"
"CHEMBL146086";"";"None";"375.41";"0";"3.19";"42";"Oc1nc2c(c3nc(-c4ccccc4F)cn13)CN(Cc1cccnc1)CC2";"EC50";"'='";"101.0";"nM";"7.00";"";"";"UO_0000065";"18.63";"0.34";"3.81";"10.51";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"101.0"
"CHEMBL45198";"";"None";"386.48";"0";"4.35";"104, MRK-529";"Cc1csc(-c2cc(-c3ccncc3)c3n(c2=O)CCCc2ccncc2-3)n1";"Activity";"'='";"37.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL2327261";"Positive allosteric modulation of GABAA alpha2 (unknown origin) relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321869";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"37.0"
"CHEMBL5275690";"";"None";"342.40";"0";"3.78";"93b";"CCOC(=O)c1nc(C)c2[nH]c3cc(OC)c(OC)cc3c2c1CC";"Ki";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"22.55";"0.42";"3.94";"10.51";"0";"CHEMBL5235568";"Binding affinity to human recombinant GABAA alpha2 receptor assessed as inhibition constant incubated for 1 hrs by liquid scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233266";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"19.0"
"CHEMBL3647575";"";"None";"438.48";"0";"4.05";"BDBM144266";"COc1cc(S(C)(=O)=O)ccc1-c1cc(-c2cnnc3c2ncn3C2CC2)ccc1F";"Ki";"'='";"37.1";"nM";"7.43";"";"280548";"UO_0000065";"16.95";"0.33";"3.38";"8.54";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"37.1"
"CHEMBL3647576";"";"None";"447.50";"0";"4.30";"BDBM144267";"CCS(=O)(=O)c1ccc(-c2cc(-c3cnnc4c3ncn4C3CC3)ccc2F)c(C#N)c1";"Ki";"'='";"170.0";"nM";"6.77";"";"280549";"UO_0000065";"15.13";"0.29";"2.47";"6.67";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"170.0"
"CHEMBL358874";"";"None";"364.38";"0";"2.52";"44";"Oc1nc2c(c3nc(-c4ccccc4F)cn13)CN(Cc1c[nH]cn1)CC2";"EC50";"'='";"459.0";"nM";"6.34";"";"";"UO_0000065";"17.39";"0.32";"3.82";"7.70";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"459.0"
"CHEMBL44533";"";"None";"385.49";"0";"4.96";"2a";"Cc1csc(-c2cc(-c3ccccc3)c3n(c2=O)CCCc2ccncc2-3)n1";"Ki";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"24.70";"0.46";"4.56";"19.93";"0";"CHEMBL678890";"Displacement of [3H]Ro-151788 from human GABA-A receptor alpha2 subunit expressed in L(tk) cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148234";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";"";"0.3"
"CHEMBL146356";"";"None";"386.45";"0";"3.67";"16";"COc1cccc(-c2cn3c(O)nc4c(c3n2)CN(Cc2ccccc2)CC4)c1";"Activity";"'='";"115.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"115.0"
"CHEMBL146356";"";"None";"386.45";"0";"3.67";"16";"COc1cccc(-c2cn3c(O)nc4c(c3n2)CN(Cc2ccccc2)CC4)c1";"EC50";"'='";"268.0";"nM";"6.57";"";"";"UO_0000065";"17.01";"0.31";"2.90";"10.45";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"268.0"
"CHEMBL147379";"";"None";"340.40";"0";"3.40";"29";"CCCCN1CCc2nc(O)n3cc(-c4ccccc4F)nc3c2C1";"EC50";"'='";"247.0";"nM";"6.61";"";"";"UO_0000065";"19.41";"0.36";"3.21";"12.31";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"247.0"
"CHEMBL344120";"";"None";"402.43";"0";"3.75";"39";"Cc1ccccc1C(=O)N1CCc2nc(O)n3cc(-c4ccccc4F)nc3c2C1";"Activity";"'='";"90.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"90.0"
"CHEMBL3647537";"";"None";"449.51";"0";"4.37";"BDBM144228";"CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)C(C)C)cc4C#N)c3)cnnc21";"Ki";"'='";"108.0";"nM";"6.97";"";"280529";"UO_0000065";"15.50";"0.30";"2.60";"6.86";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"108.0"
"CHEMBL3647567";"";"None";"460.48";"1";"5.05";"BDBM144258";"CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4C(F)F)c3)cnnc21";"Ki";"'='";"35.4";"nM";"7.45";"";"280538";"UO_0000065";"16.18";"0.32";"2.40";"9.58";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"35.4"
"CHEMBL3647544";"";"None";"436.51";"0";"4.82";"BDBM144235";"CCS(=O)(=O)c1ccc(-c2cc(-c3cnnc4c3ncn4C3CCC3)ccc2F)cc1";"Ki";"'='";"74.3";"nM";"7.13";"";"280552";"UO_0000065";"16.33";"0.31";"2.31";"9.17";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"74.3"
"CHEMBL3647534";"";"None";"414.44";"0";"3.86";"BDBM144225";"CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(C)(=O)=O)cc4F)c3)cnnc21";"Ki";"'='";"10.9";"nM";"7.96";"";"280526";"UO_0000065";"19.21";"0.37";"4.10";"10.24";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"10.9"
"CHEMBL45198";"";"None";"386.48";"0";"4.35";"104, MRK-529";"Cc1csc(-c2cc(-c3ccncc3)c3n(c2=O)CCCc2ccncc2-3)n1";"Ki";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"23.86";"0.45";"4.87";"15.20";"0";"CHEMBL2327955";"Positive allosteric modulation of GABAA alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321869";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"0.6"
"CHEMBL1681886";"";"None";"420.30";"1";"6.46";"2";"Clc1ccc(-n2nc3c(cnc4ccccc43)c2OCc2ccccc2Cl)cc1";"Efficacy";"'='";"22.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1687496";"Agonist activity at recombinant GABAA receptor subunit alpha-2 expressed in CHO cells at 3 uM by sensitive fluorometric read-out assay relative to midazolam";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"22.0"
"CHEMBL145910";"";"None";"392.41";"0";"3.94";"20";"Oc1nc2c(c3nc(-c4cc(F)ccc4F)cn13)CN(Cc1ccccc1)CC2";"EC50";"'='";"188.0";"nM";"6.73";"";"";"UO_0000065";"17.14";"0.32";"2.79";"12.53";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"188.0"
"CHEMBL1681890";"";"None";"438.36";"1";"6.58";"6";"Clc1ccc(-n2nc3c4c(ncc3c2OCc2ccccc2Cl)CCCCC4)cc1";"Efficacy";"'='";"96.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1687496";"Agonist activity at recombinant GABAA receptor subunit alpha-2 expressed in CHO cells at 3 uM by sensitive fluorometric read-out assay relative to midazolam";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"96.0"
"CHEMBL1681900";"";"None";"353.85";"0";"4.74";"17";"Clc1ccc(-n2nc3c4c(ncc3c2OCC2CC2)CCCC4)cc1";"Efficacy";"'='";"64.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1687496";"Agonist activity at recombinant GABAA receptor subunit alpha-2 expressed in CHO cells at 3 uM by sensitive fluorometric read-out assay relative to midazolam";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"64.0"
"CHEMBL146302";"";"None";"406.39";"0";"3.58";"35";"O=C(c1ccccc1F)N1CCc2nc(O)n3cc(-c4ccccc4F)nc3c2C1";"Activity";"'='";"53.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"53.0"
"CHEMBL356806";"";"None";"406.39";"0";"3.58";"36";"O=C(c1cccc(F)c1)N1CCc2nc(O)n3cc(-c4ccccc4F)nc3c2C1";"EC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"17.61";"0.33";"3.57";"10.12";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"70.0"
"CHEMBL358519";"";"None";"340.36";"0";"2.54";"52";"CCC(=O)N1CCc2nc(O)n3cc(-c4ccccc4F)nc3c2C1";"Activity";"'='";"22.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"22.0"
"CHEMBL356161";"";"None";"374.42";"0";"3.80";"10";"Oc1nc2c(c3nc(-c4ccccc4F)cn13)CN(Cc1ccccc1)CC2";"Activity";"'='";"76.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"76.0"
"CHEMBL148043";"";"None";"438.56";"1";"5.39";"23";"Oc1nc2c(c3nc(-c4ccccc4-c4cccs4)cn13)CN(Cc1ccccc1)CC2";"Activity";"'='";"194.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"194.0"
"CHEMBL146075";"";"None";"418.43";"0";"3.94";"62";"O=C(OCc1ccccc1)N1CCc2nc(O)n3cc(-c4ccccc4F)nc3c2C1";"EC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"100.0"
"CHEMBL356271";"";"None";"386.45";"0";"3.67";"17";"COc1ccc(-c2cn3c(O)nc4c(c3n2)CN(Cc2ccccc2)CC4)cc1";"Activity";"'='";"142.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"142.0"
"CHEMBL149287";"";"None";"298.32";"0";"2.23";"25";"CN1CCc2nc(O)n3cc(-c4ccccc4F)nc3c2C1";"Activity";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"0.0"
"CHEMBL358301";"";"None";"324.36";"0";"2.79";"27";"C=CCN1CCc2nc(O)n3cc(-c4ccccc4F)nc3c2C1";"Activity";"'='";"18.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"18.0"
"CHEMBL148043";"";"None";"438.56";"1";"5.39";"23";"Oc1nc2c(c3nc(-c4ccccc4-c4cccs4)cn13)CN(Cc1ccccc1)CC2";"EC50";"'='";"879.0";"nM";"6.06";"";"";"UO_0000065";"13.81";"0.26";"0.67";"11.29";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"879.0"
"CHEMBL148740";"";"None";"356.43";"0";"3.66";"9";"Oc1nc2c(c3nc(-c4ccccc4)cn13)CN(Cc1ccccc1)CC2";"Activity";"'='";"179.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"179.0"
"CHEMBL145910";"";"None";"392.41";"0";"3.94";"20";"Oc1nc2c(c3nc(-c4cc(F)ccc4F)cn13)CN(Cc1ccccc1)CC2";"Activity";"'='";"82.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"82.0"
"CHEMBL3647556";"";"None";"452.54";"0";"3.47";"BDBM144247";"CCn1cnc2c(-c3ccc(CO)c(-c4ccc(S(=O)(=O)CC)cc4OC)c3)cnnc21";"Ki";"'='";"1750.0";"nM";"5.76";"";"280570";"UO_0000065";"12.72";"0.25";"2.29";"5.37";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"1750.0"
"CHEMBL3647561";"";"None";"411.46";"0";"3.23";"BDBM144252";"CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)NC)cc4)c3)cnnc21";"Ki";"'='";"7.45";"nM";"8.13";"";"280532";"UO_0000065";"19.75";"0.38";"4.90";"9.05";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"7.45"
"CHEMBL3647572";"";"None";"408.46";"0";"4.04";"BDBM144263";"CS(=O)(=O)c1ccc(-c2cc(-c3cnnc4c3ncn4C3CC3)ccc2F)cc1";"Ki";"'='";"43.3";"nM";"7.36";"";"280545";"UO_0000065";"18.03";"0.35";"3.32";"9.47";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"43.3"
"CHEMBL3647542";"";"None";"454.50";"0";"4.96";"BDBM144233";"CCS(=O)(=O)c1ccc(-c2cc(-c3cnnc4c3ncn4C3CCC3)ccc2F)c(F)c1";"Ki";"'='";"147.0";"nM";"6.83";"";"280550";"UO_0000065";"15.03";"0.29";"1.87";"8.79";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"147.0"
"CHEMBL4744361";"";"None";"381.41";"0";"3.39";"26";"Cc1c(F)c(Nc2cnc3c(c2)OCC(=O)N3C)cc2c1ncn2CC1CC1";"Efficacy";"'='";"10.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"10.0"
"CHEMBL4746482";"";"None";"418.38";"0";"3.35";"21";"CN1C(=O)COc2cc(Nc3cc(C(F)(F)F)c4ncn(CC5CC5)c4n3)cnc21";"Efficacy";"'='";"5.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701850";"Positive allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"5.0"
"CHEMBL3647560";"";"None";"422.49";"0";"4.04";"BDBM144251";"CCn1cnc2c(-c3ccc(F)c(-c4ccc5c(c4)CC(C)S5(=O)=O)c3)cnnc21";"Ki";"'='";"69.5";"nM";"7.16";"";"280574";"UO_0000065";"16.94";"0.33";"3.12";"9.21";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"69.5"
"CHEMBL20042";"CGS-9896";"None";"295.73";"0";"3.42";"1, CGS-9896";"O=C1C2C=Nc3ccccc3C2=NN1c1ccc(Cl)cc1";"Efficacy";"'='";"47.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1687501";"Agonist activity at recombinant GABAA receptor subunit alpha-2 expressed in CHO cells at 1 uM by sensitive fluorometric read-out assay relative to midazolam";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"47.0"
"CHEMBL4748984";"";"None";"349.39";"0";"2.94";"8";"CN1C(=O)COc2cc(Nc3cc4c(cn3)ncn4CC3CC3)ccc21";"Efficacy";"'='";"2.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"2.0"
"CHEMBL4761336";"";"None";"350.38";"0";"2.34";"16";"CN1C(=O)COc2cc(Nc3cc4c(cn3)ncn4CC3CC3)ncc21";"Efficacy";"'='";"27.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"27.0"
"CHEMBL454095";"ABECARNIL";"2.0";"404.47";"1";"5.01";"90";"COCc1c(C(=O)OC(C)C)ncc2[nH]c3ccc(OCc4ccccc4)cc3c12";"Ki";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"21.51";"0.40";"3.69";"11.85";"0";"CHEMBL5235568";"Binding affinity to human recombinant GABAA alpha2 receptor assessed as inhibition constant incubated for 1 hrs by liquid scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233266";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"2.0"
"CHEMBL5290579";"";"None";"328.37";"0";"3.39";"93a";"CCc1c(C(=O)OC)nc(C)c2[nH]c3cc(OC)c(OC)cc3c12";"Ki";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"24.66";"0.46";"4.71";"11.03";"0";"CHEMBL5235568";"Binding affinity to human recombinant GABAA alpha2 receptor assessed as inhibition constant incubated for 1 hrs by liquid scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233266";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"8.0"
"CHEMBL5281056";"";"None";"258.28";"0";"3.75";"102";"c1ccc2c(c1)[nH]c1cnc3c4ccncc4[nH]c3c12";"Ki";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"29.50";"0.52";"3.87";"13.28";"0";"CHEMBL5235568";"Binding affinity to human recombinant GABAA alpha2 receptor assessed as inhibition constant incubated for 1 hrs by liquid scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233266";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"24.0"
"CHEMBL146075";"";"None";"418.43";"0";"3.94";"62";"O=C(OCc1ccccc1)N1CCc2nc(O)n3cc(-c4ccccc4F)nc3c2C1";"Activity";"'='";"8.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"8.0"
"CHEMBL3647550";"";"None";"442.49";"0";"4.81";"BDBM144241";"CCS(=O)(=O)c1ccc(-c2cc(-c3cnnc4c3ncn4C(C)C)ccc2F)c(F)c1";"Ki";"'='";"34.5";"nM";"7.46";"";"280558";"UO_0000065";"16.86";"0.33";"2.65";"9.60";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"34.5"
"CHEMBL3647543";"";"None";"436.51";"0";"4.60";"BDBM144234";"CCS(=O)(=O)c1ccc(-c2cc(-c3cnnc4c3ncn4C3(C)CC3)ccc2F)cc1";"Ki";"'='";"34.8";"nM";"7.46";"";"280551";"UO_0000065";"17.09";"0.33";"2.86";"9.59";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"34.8"
"CHEMBL4537552";"";"None";"386.43";"0";"3.61";"49; GL-II-073";"C#Cc1ccc2c(c1)C(c1ccccc1F)=N[C@H](C)c1c(C(=O)N(C)C)ncn1-2";"Ki";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"11.70";"0.21";"0.91";"8.96";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"30000.0"
"CHEMBL4764668";"";"None";"363.42";"0";"3.33";"13";"CC1Oc2cc(Nc3cc4c(cn3)ncn4CC3CC3)ccc2N(C)C1=O";"Efficacy";"'='";"54.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701850";"Positive allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"POSITIVE ALLOSTERIC MODULATOR";"";"54.0"
"CHEMBL363211";"";"None";"368.40";"0";"2.09";"37; MRK-016";"Cc1cc(-c2nncc3c(C(C)(C)C)c(OCc4ncnn4C)nn23)no1";"Efficacy";"'='";"0.06";"";"";"";"";"";"";"";"";"";"0";"CHEMBL4403771";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as reduction in DMCM induced current relative to DMCM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.06"
"CHEMBL145983";"";"None";"374.42";"0";"3.80";"11";"Oc1nc2c(c3nc(-c4cccc(F)c4)cn13)CN(Cc1ccccc1)CC2";"Activity";"'='";"81.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"81.0"
"CHEMBL343471";"";"None";"402.43";"0";"3.75";"40";"Cc1ccc(C(=O)N2CCc3nc(O)n4cc(-c5ccccc5F)nc4c3C2)cc1";"Activity";"'='";"62.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"62.0"
"CHEMBL3647546";"";"None";"424.50";"0";"4.50";"BDBM144237";"CCCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4)c3)cnnc21";"Ki";"'='";"120.0";"nM";"6.92";"";"280554";"UO_0000065";"16.30";"0.32";"2.42";"8.90";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"120.0"
"CHEMBL3647581";"";"None";"454.53";"0";"4.68";"BDBM144272";"CCS(=O)(=O)c1ccc(-c2cc(-c3cnnc4c3ncn4C(C)C)ccc2F)c(OC)c1";"Ki";"'='";"14.0";"nM";"7.85";"";"280564";"UO_0000065";"17.28";"0.34";"3.17";"9.03";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"14.0"
"CHEMBL3647582";"";"None";"449.51";"0";"4.55";"BDBM144273";"CCS(=O)(=O)c1ccc(-c2cc(-c3cnnc4c3ncn4C(C)C)ccc2F)c(C#N)c1";"Ki";"'='";"29.1";"nM";"7.54";"";"280565";"UO_0000065";"16.77";"0.32";"2.99";"7.42";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"29.1"
"CHEMBL45346";"";"None";"291.74";"0";"2.26";"36; PWZ-029";"COCc1ncn2c1CN(C)C(=O)c1cc(Cl)ccc1-2";"Efficacy";"'='";"15.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4403775";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as reduction in DMCM induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"15.0"
"CHEMBL1077391";"";"None";"292.13";"0";"2.80";"RO4882224";"Clc1ccc2c(c1)-c1ncnn1Cc1c(Cl)ncn1-2";"Ki";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"26.08";"0.55";"4.82";"15.70";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"24.0"
"CHEMBL1783247";"";"None";"334.42";"0";"3.64";"Table 2, R2C1";"CCCNC(=O)c1nnc2c(-c3cc(C)ccc3C)cccc2c1N";"FC";"'='";"0.38";"";"";"";"";"";"";"";"";"";"0";"CHEMBL4403724";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as increase in induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.38"
"CHEMBL911";"ZOLPIDEM";"4.0";"307.40";"0";"3.25";"Zolpidem";"Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1";"Activity";"'='";"291.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL678888";"Maximum percent potentiation against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"291.0"
"CHEMBL1783256";"AZD6280";"1.0";"366.42";"0";"3.04";"20; AZD6280, Table 2, R3C3";"CCCNC(=O)c1nnc2c(-c3cc(OC)ccc3OC)cccc2c1N";"FC";"'='";"0.32";"";"";"";"";"";"";"";"";"";"0";"CHEMBL4403724";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as increase in induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.32"
"CHEMBL911";"ZOLPIDEM";"4.0";"307.40";"0";"3.25";"Zolpidem";"Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1";"EC50";"'='";"737.0";"nM";"6.13";"";"";"UO_0000065";"19.95";"0.36";"2.88";"16.31";"0";"CHEMBL678889";"Effective concentration against gamma-aminobutyric acid (GABA) A receptor, alpha 2";"B";"BAO_0000357";"single protein format";"Xenopus laevis";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135642";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"737.0"
"CHEMBL4799496";"";"None";"364.41";"0";"2.64";"20";"Cc1cc(Nc2cnc3c(c2)OCC(=O)N3C)nc2c1ncn2CC1CC1";"Efficacy";"'='";"2.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701850";"Positive allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"2.0"
"CHEMBL4800521";"";"None";"367.38";"0";"3.08";"25";"CN1C(=O)COc2cc(Nc3cc4c(cc3F)ncn4CC3CC3)cnc21";"Efficacy";"'='";"7.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"7.0"
"CHEMBL1783258";"";"None";"352.39";"0";"2.65";"Table 2, R2C3";"CCNC(=O)c1nnc2c(-c3cc(OC)ccc3OC)cccc2c1N";"Ki";"'='";"29.51";"nM";"7.53";"";"";"UO_0000065";"21.37";"0.40";"4.88";"7.58";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"7.53"
"CHEMBL1783259";"";"None";"366.42";"0";"3.03";"Table 2, R4C3";"COc1ccc(OC)c(-c2cccc3c(N)c(C(=O)NC(C)C)nnc23)c1";"Ki";"'='";"56.23";"nM";"7.25";"";"";"UO_0000065";"19.79";"0.37";"4.22";"7.30";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"7.25"
"CHEMBL4441634";"";"None";"388.86";"0";"4.84";"21; NS16085";"CC(C)(O)c1ccc2c(c1)ncn2-c1cccc(-c2cc(C#N)ccc2Cl)n1";"FC";"'='";"0.27";"";"";"";"";"";"";"";"";"";"0";"CHEMBL4403724";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as increase in induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.27"
"CHEMBL1783253";"";"None";"364.41";"0";"2.79";"Table 2, R5C3";"COc1ccc(OC)c(-c2cccc3c(N)c(C(=O)NC4CC4)nnc23)c1";"FC";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4403724";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as increase in induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";""
"CHEMBL4547830";"";"None";"387.41";"0";"4.08";"47; SH-053-2'F-S-CH3";"C#Cc1ccc2c(c1)C(c1ccccc1F)=N[C@@H](C)c1c(C(=O)OCC)ncn1-2";"FC";"'='";"0.57";"";"";"";"";"";"";"";"";"";"0";"CHEMBL4403724";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as increase in induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.57"
"CHEMBL4062225";"";"None";"351.37";"0";"3.25";"38; KRM-II-81";"C#Cc1ccc2c(c1)C(c1ccccn1)=NCc1c(-c3cnco3)ncn1-2";"Ki";"'='";"118.0";"nM";"6.93";"";"";"UO_0000065";"19.72";"0.35";"3.68";"10.03";"0";"CHEMBL5384412";"Positive allosteric modulation of GABAA alpha2 receptor (unknown origin) assessed as inhibition constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380849";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"POSITIVE ALLOSTERIC MODULATOR";"";"118.0"
"CHEMBL510764";"";"None";"238.29";"0";"3.70";"87g";"CCCC(=O)c1cc2c(cn1)[nH]c1ccccc12";"Ki";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"32.72";"0.59";"4.10";"17.04";"0";"CHEMBL5235568";"Binding affinity to human recombinant GABAA alpha2 receptor assessed as inhibition constant incubated for 1 hrs by liquid scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233266";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"16.0"
"CHEMBL1783280";"";"None";"337.38";"0";"2.42";"Table 2, R5C1";"CCCNC(=O)c1nnc2c(-c3cnccc3OC)cccc2c1N";"Ki";"'='";"2.239";"nM";"8.65";"";"";"UO_0000065";"25.64";"0.47";"6.23";"8.40";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"8.65"
"CHEMBL45346";"";"None";"291.74";"0";"2.26";"36; PWZ-029";"COCc1ncn2c1CN(C)C(=O)c1cc(Cl)ccc1-2";"Ki";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"23.12";"0.46";"4.48";"14.24";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"180.0"
"CHEMBL4537371";"";"None";"342.36";"0";"2.39";"27; MP-III-024";"C#Cc1ccc2c(c1)C(c1ccccn1)=NCc1c(C(=O)OC)ncn1-2";"Activity";"'='";"140.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4403724";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as increase in induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"140.0"
"CHEMBL1077391";"";"None";"292.13";"0";"2.80";"RO4882224";"Clc1ccc2c(c1)-c1ncnn1Cc1c(Cl)ncn1-2";"Efficacy";"'='";"-9.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4403775";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as reduction in DMCM induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"-9.0"
"CHEMBL20042";"CGS-9896";"None";"295.73";"0";"3.42";"1, CGS-9896";"O=C1C2C=Nc3ccccc3C2=NN1c1ccc(Cl)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"28.40";"0.55";"4.98";"18.65";"0";"CHEMBL1687498";"Displacement of [3H]flumazenil from GABAA receptor subunit alpha-2 expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";"";"4.0"
"CHEMBL4537371";"";"None";"342.36";"0";"2.39";"27; MP-III-024";"C#Cc1ccc2c(c1)C(c1ccccn1)=NCc1c(C(=O)OC)ncn1-2";"Ki";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"17.53";"0.32";"3.61";"8.65";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"1000.0"
"CHEMBL1783256";"AZD6280";"1.0";"366.42";"0";"3.04";"20; AZD6280, Table 2, R3C3";"CCCNC(=O)c1nnc2c(-c3cc(OC)ccc3OC)cccc2c1N";"Ki";"'='";"15.14";"nM";"7.82";"";"";"UO_0000065";"21.34";"0.40";"4.78";"7.87";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"7.82"
"CHEMBL1783279";"";"None";"368.40";"0";"1.83";"Table 2, R6C1";"CCCNC(=O)c1nnc2c(-c3cnc(OC)nc3OC)cccc2c1N";"FC";"'='";"0.54";"";"";"";"";"";"";"";"";"";"0";"CHEMBL4403724";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as increase in induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.54"
"CHEMBL301605";"";"None";"257.30";"0";"4.35";"99a";"c1ccc2c(c1)[nH]c1c2ncc2[nH]c3ccccc3c21";"Ki";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"34.98";"0.61";"4.65";"20.24";"0";"CHEMBL5235568";"Binding affinity to human recombinant GABAA alpha2 receptor assessed as inhibition constant incubated for 1 hrs by liquid scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233266";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"1.0"
"CHEMBL4581355";"";"None";"376.44";"0";"4.43";"ONO-8590580";"Cc1c(F)c(Nc2ccc(-c3cn(C)cn3)cn2)cc2c1ncn2CC1CC1";"Efficacy";"'='";"5.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701850";"Positive allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"5.0"
"CHEMBL3647536";"DARIGABAT";"2.0";"440.50";"0";"4.12";"BDBM144227";"CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4OC)c3)cnnc21";"Ki";"'<'";"2.47";"nM";"";"";"280528";"UO_0000065";"";"";"";"";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"2.47"
"CHEMBL204696";"";"None";"391.38";"0";"3.84";"4; TPA023B";"CC(C)(O)c1cnn2c(-c3ccc(F)c(-c4c(F)cccc4C#N)c3)cnc2n1";"FC";"'='";"0.38";"";"";"";"";"";"";"";"";"";"0";"CHEMBL4403724";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as increase in induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.38"
"CHEMBL4571892";"";"None";"387.41";"0";"4.08";"46; SH-053-2'F-R-CH3";"C#Cc1ccc2c(c1)C(c1ccccc1F)=N[C@H](C)c1c(C(=O)OCC)ncn1-2";"FC";"'='";"0.19";"";"";"";"";"";"";"";"";"";"0";"CHEMBL4403724";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as increase in induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.19"
"CHEMBL3647536";"DARIGABAT";"2.0";"440.50";"0";"4.12";"8; PF-06372865, CVL-865";"CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4OC)c3)cnnc21";"Activity";"'>'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4403750";"Positive allosteric modulation of GABAA alpha2 (unknown origin) relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"50.0"
"CHEMBL4794167";"";"None";"350.38";"0";"2.34";"15";"CN1C(=O)COc2nc(Nc3cc4c(cn3)ncn4CC3CC3)ccc21";"Efficacy";"'='";"39.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"39.0"
"CHEMBL4796770";"";"None";"350.38";"0";"2.34";"19";"CN1C(=O)COc2cc(Nc3ccc4ncn(CC5CC5)c4n3)cnc21";"Efficacy";"'='";"2.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"2.0"
"CHEMBL4756857";"";"None";"361.41";"0";"3.65";"29";"Cc1nnc(-c2ccc(Nc3cc(C)c4ncn(CC5CC5)c4n3)nc2)o1";"Efficacy";"'='";"8.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4701825";"Negative allosteric modulation of recombinant human GABA-A alpha2 expressed in HEK293 cells assessed as reduction in GABA-induced current at 1 uM relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699487";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"";"";"8.0"
"CHEMBL3647555";"";"None";"456.96";"0";"4.64";"BDBM144246";"CCn1cnc2c(-c3ccc(Cl)c(-c4ccc(S(=O)(=O)CC)cc4OC)c3)cnnc21";"Ki";"'='";"29.7";"nM";"7.53";"";"280569";"UO_0000065";"16.47";"0.33";"2.89";"8.65";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"29.7"
"CHEMBL3647566";"";"None";"454.53";"0";"4.51";"BDBM144257";"CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)C(C)C)cc4OC)c3)cnnc21";"Ki";"'='";"11.7";"nM";"7.93";"";"280537";"UO_0000065";"17.45";"0.34";"3.42";"9.12";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"11.7"
"CHEMBL1783279";"";"None";"368.40";"0";"1.83";"Table 2, R6C1";"CCCNC(=O)c1nnc2c(-c3cnc(OC)nc3OC)cccc2c1N";"Ki";"'='";"7.413";"nM";"8.13";"";"";"UO_0000065";"22.07";"0.41";"6.30";"6.50";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"8.13"
"CHEMBL1783253";"";"None";"364.41";"0";"2.79";"Table 2, R5C3";"COc1ccc(OC)c(-c2cccc3c(N)c(C(=O)NC4CC4)nnc23)c1";"Ki";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"21.95";"0.40";"5.21";"8.05";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"8.0"
"CHEMBL1783257";"";"None";"378.43";"0";"3.18";"Table 2, R6C3";"COc1ccc(OC)c(-c2cccc3c(N)c(C(=O)NC4CCC4)nnc23)c1";"Ki";"'='";"26.3";"nM";"7.58";"";"";"UO_0000065";"20.03";"0.37";"4.40";"7.63";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"7.58"
"CHEMBL1783259";"";"None";"366.42";"0";"3.03";"Table 2, R4C3";"COc1ccc(OC)c(-c2cccc3c(N)c(C(=O)NC(C)C)nnc23)c1";"FC";"'='";"0.2";"";"";"";"";"";"";"";"";"";"0";"CHEMBL4403724";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as increase in induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.2"
"CHEMBL1783257";"";"None";"378.43";"0";"3.18";"Table 2, R6C3";"COc1ccc(OC)c(-c2cccc3c(N)c(C(=O)NC4CCC4)nnc23)c1";"FC";"'='";"0.28";"";"";"";"";"";"";"";"";"";"0";"CHEMBL4403724";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as increase in induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.28"
"CHEMBL306422";"";"None";"362.35";"0";"1.95";"35; alpha-5IA";"Cc1cc(-c2nnc3c4ccccc4c(OCc4cn(C)nn4)nn23)no1";"Efficacy";"'='";"0.1";"";"";"";"";"";"";"";"";"";"0";"CHEMBL4403771";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as reduction in DMCM induced current relative to DMCM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.1"
"CHEMBL363211";"";"None";"368.40";"0";"2.09";"37; MRK-016";"Cc1cc(-c2nncc3c(C(C)(C)C)c(OCc4ncnn4C)nn23)no1";"Ki";"'='";"0.85";"nM";"9.07";"";"";"UO_0000065";"24.62";"0.46";"6.98";"8.32";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.85"
"CHEMBL373250";"";"None";"399.41";"0";"3.07";"103, L-838417";"Cn1ncnc1COc1nn2c(-c3cc(F)ccc3F)nnc2cc1C(C)(C)C";"Activity";"'='";"34.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL2327261";"Positive allosteric modulation of GABAA alpha2 (unknown origin) relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321869";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"34.0"
"CHEMBL911";"ZOLPIDEM";"4.0";"307.40";"0";"3.25";"44";"Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1";"Inhibition";"'='";"74.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5237501";"Inhibition of GABA-A alpha2 receptor (unknown origin) relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236558";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";"";"74.1"
"CHEMBL373250";"";"None";"399.41";"0";"3.07";"103, L-838417";"Cn1ncnc1COc1nn2c(-c3cc(F)ccc3F)nnc2cc1C(C)(C)C";"Ki";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"22.92";"0.43";"6.08";"11.03";"0";"CHEMBL2327955";"Positive allosteric modulation of GABAA alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321869";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"0.7"
"CHEMBL373250";"";"None";"399.41";"0";"3.07";"1; L-838417";"Cn1ncnc1COc1nn2c(-c3cc(F)ccc3F)nnc2cc1C(C)(C)C";"FC";"'='";"0.43";"";"";"";"";"";"";"";"";"";"0";"CHEMBL4403724";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as increase in induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.43"
"CHEMBL3647568";"";"None";"428.46";"0";"4.25";"BDBM144259";"CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4F)c3)cnnc21";"Ki";"'='";"18.2";"nM";"7.74";"";"280539";"UO_0000065";"18.06";"0.35";"3.49";"9.96";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"18.2"
"CHEMBL454606";"";"None";"240.26";"0";"2.89";"87c";"CCOC(=O)c1cc2c(cn1)[nH]c1ccccc12";"Ki";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"34.55";"0.63";"5.41";"15.10";"0";"CHEMBL5235568";"Binding affinity to human recombinant GABAA alpha2 receptor assessed as inhibition constant incubated for 1 hrs by liquid scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233266";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"5.0"
"CHEMBL3647536";"DARIGABAT";"2.0";"440.50";"0";"4.12";"8; PF-06372865, CVL-865";"CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4OC)c3)cnnc21";"FC";"'='";"0.35";"";"";"";"";"";"";"";"";"";"0";"CHEMBL4403724";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as increase in induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.35"
"CHEMBL5290746";"";"None";"331.38";"0";"4.11";"88b";"COC(=O)c1cc2c(cn1)[nH]c1ccc(NCc3ccccc3)cc12";"Ki";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"22.70";"0.41";"3.41";"11.23";"0";"CHEMBL5235568";"Binding affinity to human recombinant GABAA alpha2 receptor assessed as inhibition constant incubated for 1 hrs by liquid scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233266";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"30.0"
"CHEMBL5290464";"";"None";"300.31";"0";"2.74";"89b";"CCOC(=O)c1ncc2[nH]c3ccc(O)cc3c2c1COC";"Ki";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"27.64";"0.52";"5.56";"9.83";"0";"CHEMBL5235568";"Binding affinity to human recombinant GABAA alpha2 receptor assessed as inhibition constant incubated for 1 hrs by liquid scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233266";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"5.0"
"CHEMBL5280240";"";"None";"314.34";"0";"3.05";"89c";"CCOC(=O)c1ncc2[nH]c3ccc(OC)cc3c2c1COC";"Ki";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"28.63";"0.53";"5.95";"12.25";"0";"CHEMBL5235568";"Binding affinity to human recombinant GABAA alpha2 receptor assessed as inhibition constant incubated for 1 hrs by liquid scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233266";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"1.0"
"CHEMBL49141";"";"None";"342.40";"0";"3.83";"89d";"CCCOc1ccc2[nH]c3cnc(C(=O)OCC)c(COC)c3c2c1";"Ki";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"26.29";"0.49";"5.17";"12.25";"0";"CHEMBL5235568";"Binding affinity to human recombinant GABAA alpha2 receptor assessed as inhibition constant incubated for 1 hrs by liquid scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233266";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"1.0"
"CHEMBL52030";"";"None";"341.37";"0";"2.35";"105, L-655708";"CCOC(=O)c1ncn2c1[C@@H]1CCCN1C(=O)c1cc(OC)ccc1-2";"Ki";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"22.17";"0.41";"5.22";"10.28";"0";"CHEMBL2327955";"Positive allosteric modulation of GABAA alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321869";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"27.0"
"CHEMBL363211";"";"None";"368.40";"0";"2.09";"106, MRK-016";"Cc1cc(-c2nncc3c(C(C)(C)C)c(OCc4ncnn4C)nn23)no1";"Ki";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"24.69";"0.46";"7.01";"8.34";"0";"CHEMBL2327955";"Positive allosteric modulation of GABAA alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321869";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"0.8"
"CHEMBL3647562";"";"None";"396.45";"0";"3.72";"BDBM144253";"CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(C)(=O)=O)cc4)c3)cnnc21";"Ki";"'='";"17.7";"nM";"7.75";"";"280533";"UO_0000065";"19.55";"0.38";"4.03";"9.97";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"17.7"
"CHEMBL1783282";"AZD7325";"2.0";"354.39";"0";"3.17";"6; AZD7325, Table 2, R4C1";"CCCNC(=O)c1nnc2c(-c3c(F)cccc3OC)cccc2c1N";"Ki";"'='";"0.309";"nM";"9.51";"";"";"UO_0000065";"26.83";"0.50";"6.34";"10.55";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"9.51"
"CHEMBL5266498";"";"None";"284.31";"0";"3.04";"89a";"CCOC(=O)c1ncc2[nH]c3ccccc3c2c1COC";"Ki";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"29.98";"0.55";"5.48";"13.27";"0";"CHEMBL5235568";"Binding affinity to human recombinant GABAA alpha2 receptor assessed as inhibition constant incubated for 1 hrs by liquid scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233266";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"3.0"
"CHEMBL3647559";"";"None";"410.47";"0";"4.11";"BDBM144250";"CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4)c3)cnnc21";"Ki";"'='";"21.7";"nM";"7.66";"";"280573";"UO_0000065";"18.67";"0.36";"3.55";"9.86";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"21.7"
"CHEMBL363211";"";"None";"368.40";"0";"2.09";"106, MRK-016";"Cc1cc(-c2nncc3c(C(C)(C)C)c(OCc4ncnn4C)nn23)no1";"Activity";"'='";"4.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL2327261";"Positive allosteric modulation of GABAA alpha2 (unknown origin) relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321869";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"4.0"
"CHEMBL6597";"Ro-154513";"None";"326.32";"0";"2.58";"34; Ro15-4513";"CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(N=[N+]=[N-])ccc1-2";"Ki";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"24.99";"0.46";"5.57";"7.20";"0";"CHEMBL5341719";"Binding affinity to GABAa alpha2 (unknown origin) assessed as inhibition constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5338767";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"7.0"
"CHEMBL453066";"BETA-CCM";"None";"226.24";"0";"2.50";"87b";"COC(=O)c1cc2c(cn1)[nH]c1ccccc12";"Ki";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"36.05";"0.66";"5.65";"14.83";"0";"CHEMBL5235568";"Binding affinity to human recombinant GABAA alpha2 receptor assessed as inhibition constant incubated for 1 hrs by liquid scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233266";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"7.0"
"CHEMBL3647539";"";"None";"452.51";"0";"4.26";"BDBM144230";"CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)C5CC5)cc4OC)c3)cnnc21";"Ki";"'='";"9.71";"nM";"8.01";"";"280531";"UO_0000065";"17.71";"0.34";"3.75";"9.21";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"9.71"
"CHEMBL475022";"";"None";"356.39";"0";"2.78";"26; HZ-166";"C#Cc1ccc2c(c1)C(c1ccccn1)=NCc1c(C(=O)OCC)ncn1-2";"FC";"'='";"0.52";"";"";"";"";"";"";"";"";"";"0";"CHEMBL4403724";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as increase in induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.52"
"CHEMBL12";"DIAZEPAM";"4.0";"284.75";"0";"3.15";"Diazepam";"CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21";"Ki";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"27.29";"0.53";"4.62";"23.78";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"17.0"
"CHEMBL5272616";"";"None";"384.91";"0";"4.55";"43";"CCCN(CCC)C(=O)Cc1c(-c2ccc(C)cc2)nc2ccc(Cl)nn12";"Inhibition";"'='";"98.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5237501";"Inhibition of GABA-A alpha2 receptor (unknown origin) relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236558";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";"";"98.6"
"CHEMBL407";"FLUMAZENIL";"4.0";"303.29";"0";"1.77";"SID90341071";"CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2";"Ki";"'='";"0.7943";"nM";"9.10";"";"";"UO_0000065";"30.00";"0.56";"7.33";"14.12";"0";"CHEMBL4837571";"Binding affinity to GABBA alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4837182";"1";"Scientific Literature";"J Nat Prod";"2021";"None";"";"BINDING AGENT";"";"9.1"
"CHEMBL3647565";"";"None";"426.47";"0";"3.73";"BDBM144256";"CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(C)(=O)=O)cc4OC)c3)cnnc21";"Ki";"'='";"7.48";"nM";"8.13";"";"280536";"UO_0000065";"19.05";"0.37";"4.40";"9.34";"0";"CHEMBL3706142";"Radioligand Competition Binding Assay: The affinity of the test compounds was determined by radioligand competition binding assay, using the known compound [3H]Ro-15-1788 (Flumazenil) (Perkin Elmer, 85.4 Ci/mmol) and the human recombinant GABA A receptor containing the alpha2, beta2, and gamma3 subunits.Membranes were prepared from HEK cells expressing hGABA A alpha2beta2- gamma3 receptor, and validated to ascertain protein concentration, receptor expression and to determine the Kd of the flumazenil as well as the Ki of a standard set of compounds before being used to test new compounds.The assay was carried out in 96 well plates; testing compounds using a 10 point semi-log dilution range from 19 uM top concentration. 100 ul of radioligand and 100 ul of membrane in 50 mM Tris-HCI and 0.05% F127 with 1 ul of test compound was incubated for 2 hours to allow the reaction to achieve equilibrium, and then harvested onto filter plates, dried and counted on a TopCount NXT. The data was analysed, and the Ki values were presented.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638710";"37";"BindingDB Patent Bioactivity Data";"";"2015";"CHEMBL3307715";"";"";"";"7.48"
"CHEMBL3681419";"BASMISANIL";"2.0";"445.47";"0";"2.63";"39; RG1662";"Cc1onc(-c2ccc(F)cc2)c1COc1ccc(C(=O)N2CCS(=O)(=O)CC2)cn1";"Ki";"'='";"502.0";"nM";"6.30";"";"";"UO_0000065";"14.14";"0.28";"3.67";"6.14";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"502.0"
"CHEMBL178942";"";"None";"383.45";"0";"4.52";"9";"c1ccc(-c2nnc3c4c(c(OCc5ccccn5)nn23)C2CCC4CC2)cc1";"Ki";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"19.78";"0.36";"3.07";"11.63";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"26.0"
"CHEMBL1783282";"AZD7325";"2.0";"354.39";"0";"3.17";"6; AZD7325, Table 2, R4C1";"CCCNC(=O)c1nnc2c(-c3c(F)cccc3OC)cccc2c1N";"Ki";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"26.87";"0.50";"6.35";"10.57";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.3"
"CHEMBL4476044";"";"None";"353.43";"0";"4.79";"5; NS11394";"CC(C)(O)c1ccc2c(c1)ncn2-c1cccc(-c2ccccc2C#N)c1";"FC";"'='";"0.26";"";"";"";"";"";"";"";"";"";"0";"CHEMBL4403724";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as increase in induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.26"
"CHEMBL1783282";"AZD7325";"2.0";"354.39";"0";"3.17";"6; AZD7325, Table 2, R4C1";"CCCNC(=O)c1nnc2c(-c3c(F)cccc3OC)cccc2c1N";"FC";"'='";"0.19";"";"";"";"";"";"";"";"";"";"0";"CHEMBL4403724";"Binding affinity to GABA-A alpha2 (unknown origin) assessed as increase in induced current relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.19"
"CHEMBL204696";"";"None";"391.38";"0";"3.84";"4; TPA023B";"CC(C)(O)c1cnn2c(-c3ccc(F)c(-c4c(F)cccc4C#N)c3)cnc2n1";"Ki";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"22.23";"0.41";"4.86";"9.99";"0";"CHEMBL4403717";"Binding affinity to GABA-A alpha2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4956";"GABA receptor alpha-2 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402545";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"2.0"
